Key Points:
·In the latest lawsuit, Juul Labs has filed a lawsuit against NJOY and Altria, accusing NJOY's DAILY e-cigarette of patent infringement. The case has been submitted to the United States International Trade Commission (ITC) and federal court.
·The dispute dates back to 2023 when Altria, after divesting its ownership of Juul, acquired NJOY. It is alleged that NJOY's products developed in China violate Juul's patents.
·Previously, Juul won a case against NJOY in the ITC earlier in 2025, resulting in a ban on importing NJOY ACE products into the United States due to infringement. The ITC also dismissed Altria's patent lawsuit against Juul, finding that their patents were not infringed.
·In future developments, Altria plans to restart its federal court lawsuit against Juul based on previously unsupported patents.
According to an announcement on Juul Labs' official website on August 8th, Juul Labs has filed a lawsuit against NJOY company and Altria Group (Altria) with the United States International Trade Commission (ITC) and the Federal District Court for the District of Arizona. The lawsuit accuses NJOY's DAILY e-cigarette product of infringing on a patent owned by Juul Labs.
The current lawsuit is the latest development in a series of disputes between the two companies since 2023. In that year, Altria Group completely divested its ownership in Juul Labs and did not obtain the necessary licenses to use Juul Labs' intellectual property. Subsequently, Altria Group acquired NJOY and its products developed in China, which infringed upon Juul Labs' patented technology.
The recent lawsuit was initiated following Juul Labs' victory earlier in 2025 at the International Trade Commission. At that time, the International Trade Commission ruled that the NJOY ACE e-cigarette product developed by Altria Group in China infringed on four patents claimed by Juul Labs, and banned the import of the product to the United States.
In the same month, the International Trade Commission also terminated another patent infringement lawsuit filed by Altria Group against Juul Labs, as it determined that the patents claimed by Altria Group were not infringed.
Recently, Altria Group informed Juul Labs that it plans to restart federal court litigation against Juul Labs based on the same batch of patents that did not receive support in the International Trade Commission lawsuit against Juul Labs.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
